Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group

Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pathol Transl Med
Main Authors: Chang, Sunhee, Shim, Hyo Sup, Kim, Tae Jung, Choi, Yoon-La, Kim, Wan Seop, Shin, Dong Hoon, Kim, Lucia, Park, Heae Surng, Lee, Geon Kook, Lee, Chang Hun
Format: Artigo
Jezik:Inglês
Izdano: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8141968/
https://ncbi.nlm.nih.gov/pubmed/33966368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2021.03.23
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki